Search
for
Sort by
Research 271–300 of 1000+
- Understanding Polycystic Ovary Syndrome
- <i>In Vitro</i> Analysis of Finasteride Activity against Candida albicans Urinary Biofilm Formation and Filamentation
- Comprehensive analysis of minoxidil effectiveness for hair growth
- Safety and efficacy of oral administrated cepharanthine in non-hospitalized, asymptomatic or mild COVID-19 patients: a Double-blind, randomized, placebo-controlled trial
- Characterizing clinical and hormonal profiles of acne in north African women with polycystic ovary syndrome
- The articulations of Adam's rib with the lower urinary tract
- Hydroxychloroquine, nitazoxanide and ivermectin have similar effects in early COVID-19: a head-to-head comparison of the Pre-AndroCoV Trial.
- A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol
- Prediction and Demonstration of Retinoic Acid Receptor Agonist Ch55 as an Antifibrotic Agent in the Dermis
- Effects of natural products on skin inflammation caused by abnormal hormones secreted by the adrenal gland
- Hydroxychloroquine and Chloroquine in Prophylaxis and Treatment of COVID-19
- Undesirable effects of COVID-19 vaccination on Saudi population: A descriptive study, Winter 2022.
- Inhibition of mitochondrial respiration prevents BRAF-mutant melanoma brain metastasis
- Psychiatric disorders in women with polycystic ovary syndrome
- Novel Synthetic Steroid Derivatives: Target Prediction and Biological Evaluation of Antiandrogenic Activity
- Circulating MicroRNA Signatures in Severe Alopecia Areata: Diagnostic Discrimination, Pathway Analysis, and Therapeutic Implications
- Unique Circulating MicroRNA Signatures Distinguish Severe Alopecia Areata from Other Inflammatory Skin Diseases
- 801 TEC family kinase inhibitors as a novel class of therapeutics in alopecia areata
- Gynecological and dermatological aspects of diagnostics of polycystic ovary syndrome from puberty to menopause
- FETAL METABOLIC PROGRAMMING IN THE ETIOLOGY OF POLYCYSTIC OVARIAN SYNDROME
- Do Pleiotropic Effects of Spironolactone in Women with PCOS make it More Than an Anti-Androgen? Evidence from a Systematic Review and Meta-Analysis
- JAK Inhibitors for Treatment of Alopecia Areata
- Antiviral Drugs Screening for Swine Acute Diarrhea Syndrome Coronavirus
- Are Nutraceuticals Effective in COVID-19 and Post-COVID Prevention and Treatment?
- Therapeutic potential of <i>Asiaticoside</i> in wound healing after endoscopic submucosal dissection (ESD)
- Exploring the mechanism of Platycladi Cacumen in intervening androgenetic alopecia based on network pharmacology, molecular docking, and molecular dynamics simulation
- Botulinum toxin therapy for androgenetic alopecia: From mechanistic insights to clinical applications
- Post Covid telogen effluvium: the diagnostic value of serum ferritin biomarker and the preventive value of dietary supplements. a case control study
- Bachmann–Bupp syndrome and treatment
- SARS-CoV-2 Spike Protein S1-Mediated Endothelial Injury and Pro-Inflammatory State Is Amplified by Dihydrotestosterone and Prevented by Mineralocorticoid Antagonism